Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Somri-Gannam

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Translational Oncology|May 20, 2020
IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian CancerLina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|May 15, 2023
Removal of Contaminated Personal Protective Equipment With and Without Supervision. A Randomized Crossover Simulation-Based StudyMostafa Somri, Ohad Hochman, Lina Somri-Gannam, et al.
Frontiers in Oncology|October 25, 2024
IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancerLina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, et al.
Frontiers in Endocrinology|July 5, 2021
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade DiseaseLaris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, et al.
Cell Death & Disease|March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Translational Oncology|May 20, 2020
IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian CancerLina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|May 15, 2023
Removal of Contaminated Personal Protective Equipment With and Without Supervision. A Randomized Crossover Simulation-Based StudyMostafa Somri, Ohad Hochman, Lina Somri-Gannam, et al.
Frontiers in Oncology|October 25, 2024
IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancerLina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, et al.
Frontiers in Endocrinology|July 5, 2021
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade DiseaseLaris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, et al.
Cell Death & Disease|March 28, 2025
Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)Anat Klein-Goldberg, Tali Voloshin, Efrat Zemer Tov, et al.
Pageof 1